In a recently published study, it was shown that more than two-thirds of people with a rare type of melanoma, Desmoplastic Melanoma, responded to treatment with anti-PD-1 immunotherapies.
This blog is focused on providing people who have been diagnosed with either a rare cancer or with more than one cancer a place where they can keep up with information, research and discoveries that could impact their lives in the near term.
Rare cancers and multiple cancers have been ignored for too long. Research dollars are far too limited.
Please let us know if you hear of anything new that needs to be shared with our community.
